
Cancer study shows 'striking' results
Date: Thursday, October 09 2003 Topic: Science & Technology
A major Canadian-led study has been stopped early because the drug being tested showed "striking" results in preventing breast cancer survivors from having a recurrence.
In the study, women taking letrozole (also known as femara) had half as many recurrences of cancer as those women on a placebo.
Read the full story at CBC.ca
|
|